{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:40:10Z","timestamp":1783381210379,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.transproceed.2022.04.017","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T17:21:09Z","timestamp":1654190469000},"page":"2035-2041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["In Vitro Study Evaluating the Effect of Different Immunosuppressive Agents on Human Polyomavirus BK Replication"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6465-428X","authenticated-orcid":false,"given":"Evaldo","family":"Favi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Signorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dolci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Ticozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Ferraresso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Delbue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2022.04.017_bib0001","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(71)91776-4","article-title":"New human papovavirus (B.K.) isolated from urine after renal transplantation","volume":"1","author":"Gardner","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/0-387-32957-9_2","article-title":"Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV)","volume":"577","author":"Knowles","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0003","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/CMR.00074-16","article-title":"BK polyomavirus: clinical aspects, immune regulation, and emerging therapies","volume":"30","author":"Ambalathingal","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0004","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ndt\/gfu023","article-title":"BK virus infection: an update on diagnosis and treatment","volume":"30","author":"Sawinski","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0005","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/0-387-32957-9_11","article-title":"Polyomavirus-associated nephropathy in renal transplantation: critical issues of screening and management","volume":"577","author":"Hirsch","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0006","doi-asserted-by":"crossref","first-page":"270","DOI":"10.12998\/wjcc.v7.i3.270","article-title":"Incidence, risk factors, and outcome of BK polyomavirus infection after kidney transplantation","volume":"7","author":"Favi","year":"2019","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0007","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0008","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1309\/AJCP63VDFCKCRUUL","article-title":"Monitoring of BK viral load in renal allograft recipients by real-time PCR assays","volume":"133","author":"Bechert","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0009","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1517\/14740338.2010.495714","article-title":"Immunosuppressive agents as risk factors for BK virus nephropathy: an overview and update","volume":"9","author":"Manitpisitkul","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0010","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/00007890-199903270-00022","article-title":"Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss","volume":"67","author":"Binet","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0011","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.trre.2015.02.004","article-title":"The prevalence and implications of BK virus replication in non-renal solid organ transplant recipients: a systematic review","volume":"29","author":"Viswesh","year":"2015","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0012","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/TP.0b013e3181d0e15e","article-title":"Treatment of polyomavirus infection in kidney transplant recipients: a systematic review","volume":"89","author":"Johnston","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0013","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/TP.0b013e3182007be2","article-title":"Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection","volume":"90","author":"Liacini","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0014","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2215\/CJN.13221216","article-title":"CMV and BKPyV infections in renal transplant recipients receiving an mTOR inhibitor-based regimen versus a CNI-based regimen: a systematic review and meta-analysis of randomized, controlled trials","volume":"12","author":"Mallat","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0015","doi-asserted-by":"crossref","first-page":"e13058","DOI":"10.1111\/tid.13058","article-title":"Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: a multicenter retrospective study","volume":"21","author":"Keller","year":"2019","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0016","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/TP.0b013e31816a33d4","article-title":"Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study","volume":"85","author":"Alm\u00e9ras","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0017","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.2215\/CJN.05691207","article-title":"Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies","volume":"3","author":"Weiss","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0018","doi-asserted-by":"crossref","first-page":"167","DOI":"10.23876\/j.krcp.2018.37.2.167","article-title":"Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients","volume":"37","author":"Park","year":"2018","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0019","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e31819cc383","article-title":"An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States","volume":"87","author":"Dharnidharka","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0020","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1681\/ASN.2018010009","article-title":"Everolimus with reduced calcineurin inhibitor exposure in renal transplantation","volume":"29","author":"Pascual","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0021","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/ajt.15480","article-title":"Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study","volume":"19","author":"Berger","year":"2019","journal-title":"Am J Transplant"},{"issue":"2S","key":"10.1016\/j.transproceed.2022.04.017_bib0022","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/TP.0000000000001777","article-title":"The role of mTOR inhibitors in the management of viral infections: a review of current literature","volume":"102","author":"Bowman","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0023","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/ajt.13541","article-title":"BK polyomavirus replication in renal tubular epithelial cells is inhibited by sirolimus, but activated by tacrolimus through a pathway involving FKBP-12","volume":"16","author":"Hirsch","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0024","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1399-3062.2008.00330.x","article-title":"In vitro effect of cyclosporin A on primary and chronic BK polyoma virus infection in Vero E6 cells","volume":"10","author":"Acott","year":"2008","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1432-2277.2008.00766.x","article-title":"Suppression of early and chronic BK polyoma virus replication by mycophenolic acid in Vero cells","volume":"22","author":"Acott","year":"2009","journal-title":"Transplant Int"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0026","doi-asserted-by":"crossref","first-page":"11912","DOI":"10.1002\/jcp.27871","article-title":"Characterization of an in vitro model to study the possible role of polyomavirus BK in prostate cancer","volume":"234","author":"Villani","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0027","doi-asserted-by":"crossref","first-page":"e13528","DOI":"10.1111\/ctr.13528","article-title":"BK polyomavirus in solid organ transplantation-guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Hirsch","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0028","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-6143.2012.04320.x","article-title":"Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0029","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1432-2277.2009.00842.x","article-title":"Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States","volume":"22","author":"Schold","year":"2009","journal-title":"Transplant Int"},{"issue":"13","key":"10.1016\/j.transproceed.2022.04.017_bib0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2369-13-68","article-title":"A multicenter, randomized, double-blind study comparing different FK778 doses (manitimus) with tacrolimus and steroids vs. MMF with tacrolimus and steroids in renal transplantation","author":"Wlodarczyk","year":"2012","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0031","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.TP.0000149338.97084.5F","article-title":"Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system","volume":"79","author":"Farasati","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0032","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1128\/JVI.01737-09","article-title":"Leflunomide inhibition of BK virus replication in renal tubular epithelial cells","volume":"84","author":"Bernhoff","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0033","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","article-title":"Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction","volume":"5","author":"Brennan","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0034","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/TP.0b013e3181aa8d93","article-title":"Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study","volume":"88","author":"Manitpisitkul","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0035","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1111\/j.1600-6143.2010.03310.x","article-title":"Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy","volume":"10","author":"Schaub","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0036","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/ndt\/gfy346","article-title":"Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes","volume":"34","author":"Bischof","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15171\/jnp.2016.01","article-title":"Place of mTOR inhibitors in management of BKV infection after kidney transplantation","volume":"5","author":"Jouve","year":"2016","journal-title":"J Nephropathol"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0038","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12122","article-title":"mTOR kinase structure, mechanism and regulation","volume":"497","author":"Yang","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0039","article-title":"Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients","volume":"12","author":"Hahn","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.transproceed.2022.04.017_bib0040","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/tid.12601","article-title":"Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients","volume":"18","author":"Pascual","year":"2016","journal-title":"Transplant Infect Dis"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522003335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522003335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:42:28Z","timestamp":1758577348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134522003335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0041134522003335"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.04.017","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vitro Study Evaluating the Effect of Different Immunosuppressive Agents on Human Polyomavirus BK Replication","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}